A team of researchers at the RIKEN Center for Biosystems Dynamics Research in Kobe, Japan, may have just found an answer to hair loss and baldness woes. While many methods have been devised in the past to address hair-related issues, this one is unique, for its a recipe for continuous cyclical regeneration of hair follicles from hair follicle stem cells. At RIKENs, a team led by Takashi Tsuji had been working on methods to regenerate lost hair from stem cells
Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size, Status And Forecast 2021-2028 MarketInsightsReports, a leading global market research firm, is pleased to announce its new report on Hematopoietic Stem Cell Transplantation (HSCT) market, forecast for 2021-2028, covering all aspects of the market and providing up-to-date data on current trends. The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry.
June 4, 2021 John Theurer Cancer Center investigators report new findings at American Society of Clinical Oncology 2021 Annual Meeting Researchers from Hackensack University Medical Centers John Theurer Cancer Center, a part of Georgetown Lombardi Comprehensive Cancer Center, are presenting data from 25 studies at the Annual Meeting of the American Society of Clinical Oncology, the largest gathering of cancer professionals in the country. This years meeting is being held virtually June 4-8, 2021
SAN DIEGOandSTOCKHOLM, Sweden, June 04, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento")today announced that the Company has entered into an additional collaborative agreement with NextGenNK Competence Center-associated research groups at the Department of Medicine, Huddinge, KarolinskaInstitutet(KI) inStockholm, Sweden, aimed at producing novelcell-based therapeutics using natural killer (NK) cells derived from induced pluripotent stem cells (iPSCs).
Global Autologous Stem Cell and Non-Stem Cell Based Therapies Marketresearch report has set a bench-marking example for such a vibrant market that explores several recommendations and practical growth strategies in relation to the market. The chapter on the competitive landscape is presented well in the research report and is analyzed based on the tools such as Porters five forces analysis. This market research document produced covers numerous growth prospects in recent times with linkage in the coming decades
The acquisition provides the companies with shared scientific knowledge and resources leading to a stronger foundation for advancing newborn stem cell research TORONTO, June 2, 2021 /CNW/ -- The Cell Care international umbilical cord blood and tissue banking group, which incorporates Insception Biosciences Inc. (Insception) in Canada, today announced that it has been acquired by Generate Life Sciences (Generate).* Generate operates Cord Blood Registry (CBR), North America's largest cord blood bank and one of the world's preeminent stem cell R&D organizations. Insception joins CBR to create a unique, international scientific collaboration to further newborn stem cell and regenerative medicine research.
Therapy with Blincyto (blinatumomab), a CD19 BiTE (bispecific T-cell engager), demonstrated a longer survival time for patients with relapsed/refractory acute lymphoblastic leukemia, according to data published in Cancer. Allogenic hematopoietic stem cell transplantation was typically viewed as the only curative option for patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia, according to the studys introduction. Blincyto has previously been shown to be a potential therapy with long-term survival benefit even without hematopoietic stem cell transplantation
Karen Hasty, PhD, a professor, researcher, and director of Basic Research in the Department of Orthopaedic Surgery and Biomedical Engineering/Campbell Clinic in the College of Medicine at the University of Tennessee Health Science Center, has been named among the 2021 Super Women in Business by the Memphis Business Journal. The annual list honors women business leaders for their career accomplishments and work in the Memphis community.
Apart from culture media, surface coatings, and pluripotency level of the cells you work with, the cell density is the fourth major contributor to experimental success. Intercellular signaling is difficult to control, but seeding cells at the right concentration can significantly contribute towards getting the directed differentiation of interest
Hundreds of U.S. stem cell clinics selling experimental therapies without an FDA permit can expect to face the agencys enforcement arm and potential action from the federal government
Recent Comments